Apr 30 |
Novo, Teva, AstraZeneca issued FTC warnings over ‘bogus’ patents
|
Apr 30 |
AstraZeneca PLC (NASDAQ:AZN) Q1 2024 Earnings Call Transcript
|
Apr 29 |
AstraZeneca Admits Its COVID-19 Vaccine May Cause Blood Clotting Side Effect In Very Rare Case, But Causal Mechanism Unknown
|
Apr 29 |
AstraZeneca’s Fasenra: Approval for asthma may initiate COPD approval
|
Apr 29 |
AstraZeneca Says Enhertu Phase 3 Trial Shows 'Statistically Significant' Progression-Free Breast Cancer Survival Improvement
|
Apr 29 |
AstraZeneca's Enhertu buoyed by progression-free survival data in breast cancer
|
Apr 29 |
AstraZeneca, Daiichi look to broaden Enhertu use again with new study data
|
Apr 29 |
ENHERTU® (fam-trastuzumab deruxtecan-nxki) improved PFS in HER2-low and ultralow
|
Apr 29 |
Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week
|
Apr 28 |
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
|